Thrombotic risk stratification by platelet count in patients with antiphospholipid antibodies: a longitudinal study
- 1 September 2017
- journal article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 15 (9) , 1782-1787
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Efficacy of the antiphospholipid score for the diagnosis of antiphospholipid syndrome and its predictive value for thrombotic eventsArthritis & Rheumatism, 2011
- The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopeniaBlood, 2011
- Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (II): thrombocytopenia and skin manifestationsLupus, 2011
- Update of the guidelines for lupus anticoagulant detectionJournal of Thrombosis and Haemostasis, 2009
- Anti–β2‐glycoprotein I antibodies in complex with β2‐glycoprotein I can activate platelets in a dysregulated manner via glycoprotein Ib‐IX‐VArthritis & Rheumatism, 2006
- International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)Journal of Thrombosis and Haemostasis, 2006
- The association of thrombocytopenia with systemic manifestations in the antiphospholipid syndromeImmunobiology, 2005
- Antiphospholipid antibodies and antiphospholipid syndrome in patients presenting with immune thrombocytopenic purpura: a prospective cohort studyBlood, 2001
- Thrombocytopenia in the antiphospholipid syndromeAnnals of the Rheumatic Diseases, 1997
- Specificity of ELISA for antibody to beta 2-glycoprotein I in patients with antiphospholipid syndromeRheumatology, 1996